INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FROM THE PHASE 3 CARDINAL STUDY

被引：0
|
作者：
Roeth, A. [1 ]
Barcellini, W. [2 ]
D'Sa, S. [3 ]
Miyakawa, Y. [4 ]
Broome, C. M. [5 ]
Michel, M. [6 ]
Kuter, D. J. [7 ]
Jilma, B. [8 ]
Tvedt, T. H. Anderson [9 ]
Lin, S. [10 ]
Jiang, X. [10 ]
Reuter, C.
Hobbs, W. [10 ]
Berentsen, S. [11 ]
机构：
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol, West German Canc Ctr, Essen, Germany
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[3] Univ Coll London Hosp NHS Fdn Trust, UCLH Ctr Waldenstroms Macroglobulinemia & Related, London, England
[4] Saitama Med Univ Hosp, Ctr Thrombosis & Hemostasis, Saitama, Japan
[5] MedStar Georgetown Univ Hosp, Div Hematol, Washington, DC USA
[6] UPEC, Henri Mondor Univ Hosp, Assistance Publ Hop Paris, Creteil, France
[7] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol, Boston, MA 02115 USA
[8] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria
[9] Haukeland Hosp, Sect Hematol, Dept Med, Bergen, Norway
[10] Sanofi, Waltham, MA USA
[11] Haugesund Hosp, Dept Res & Innovat, Haugesund, Norway
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C028
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [41] DECADE Trial: Inhibition of theterminal complement system using the anti-C5 antibody eculizumab for the treatment of cold agglutinin disease (CAD)
    Roeth, A.
    Huettmann, A.
    Duehrsen, U.
    [J]. ONKOLOGIE, 2010, 33 : 112 - 112
  • [42] TNT009, a monoclonal antibody inhibitor of C1s, induces a rapid and complete remission of anemia in primary cold agglutinin disease patients
    Panicker, Sandip
    Parry, Graham C.
    Fillitz, Michael
    Schenk, Thomas
    Sillaber, Christian
    Bartko, Johann
    Gilbert, James C.
    Jaeger, Ulrich
    Jilma, Bernd
    [J]. IMMUNOBIOLOGY, 2016, 221 (10) : 1170 - 1171
  • [43] Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension
    Roeth, Alexander
    Broome, Catherine M.
    Barcellini, Wilma
    Jilma, Bernd
    Hill, Quentin A.
    Cella, David
    Tvedt, Tor Henrik Anderson
    Yamaguchi, Masaki
    Murakhovskaya, Irina
    Lee, Michelle
    Shafer, Frank
    Wardecki, Marek
    Jayawardene, Deepthi
    Yoo, Ronnie
    Msihid, Jerome
    Weitz, Ilene C.
    [J]. ECLINICALMEDICINE, 2024, 74
  • [44] Sutimlimab provides sustained improvements in patient-reported outcomes and quality of life in patients with cold agglutinin disease: open-label extension of the randomized, Phase 3 CADENZA Study
    Roth, A.
    Broome, C. M.
    Barcellini, W.
    Jilma, B.
    Hill, Q. A.
    Cella, D.
    Tvedt, T. H. A.
    Yamaguchi, M.
    Murakhovskaya, I
    Lee, M.
    Shafer, F.
    Wardecki, M.
    Wang, J.
    Yoo, R.
    Msihid, J.
    Weitz, I. C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 297 - 297
  • [45] Inhibition of complement C3 in geographic atrophy with NGM621: Phase 1 study results
    Eichenbaum, David Aaron
    Wykoff, Charles C.
    Hershberger, Vrinda
    Henry, Erin
    Younis, Husam
    Chandra, Pia
    Ly, Neang
    Yuan, Nancy
    DePaoli, Alex
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [46] Sutimlimab Provides Sustained Improvements in Patient-Reported Outcomes and Quality of Life in Patients with Cold Agglutinin Disease: Open-Label Extension of the Randomized, Phase 3 Cadenza Study
    Roeth, Alexander
    Broome, Catherine M.
    Barcellini, Wilma
    Jilma, Bernd
    Hill, Quentin A.
    Cella, David
    Tvedt, Tor Henrik Anderson
    Yamaguchi, Masaki
    Murakhovskaya, Irina
    Lee, Michelle
    Shafer, Frank
    Wardecki, Marek
    Wang, Jennifer
    Yoo, Ronnie
    Mshijid, Jerome
    Weitz, Ilene C.
    [J]. BLOOD, 2022, 140
  • [47] Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s
    Garrigues, Ryan J.
    Thomas, Sheila
    Leong, John M.
    Garcia, Brandon L.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (11)
  • [48] Classical Complement Inhibition By SAR445088 (BIVV020) in Adults with Cold Agglutinin Disease: Safety, Tolerability and Activity Results from the Open-Label, Non-Randomized, Single-Dose Phase 1b Study
    D'Sa, Shirley
    Vos, Josephine M. I.
    Barcellini, Wilma
    Wardecki, Marek
    Perrin, Laurent
    Barker, Graham
    Zilberstein, Moshe
    Storek, Michael
    Chow, Timothy
    Roeth, Alexander
    [J]. BLOOD, 2023, 142
  • [49] Inhibition of the C1s Protease and the Classical Complement Pathway by 6-(4-Phenylpiperazin-1-yl)Pyridine-3-Carboximidamide and Chemical Analogs
    Xu, Xin
    Herdendorf, Timothy J.
    Duan, Huiquan
    Rohlik, Denise L.
    Roy, Sourav
    Zhou, Hinman
    Alkhateeb, Haya
    Khandelwal, Sanjay
    Zhou, Qilong
    Li, Ping
    Arepally, Gowthami M.
    Walker, John K.
    Garcia, Brandon L.
    Geisbrecht, Brian, V
    [J]. JOURNAL OF IMMUNOLOGY, 2024, 212 (04): : 689 - 701
  • [50] Sargramostim in patients with Crohn’s disease: results of a phase 1–2 study
    Masakazu Takazoe
    Toshiyuki Matsui
    Satoshi Motoya
    Takayuki Matsumoto
    Toshifumi Hibi
    Mamoru Watanabe
    [J]. Journal of Gastroenterology, 2009, 44
12345